Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
Follow-Up Questions
¿Quién es el CEO de ACRO Biomedical Co Ltd?
Mr. Pao-Chi Chu es el President de ACRO Biomedical Co Ltd, se unió a la empresa desde 2017.
¿Qué tal es el rendimiento del precio de la acción ACBM?
El precio actual de ACBM es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de ACRO Biomedical Co Ltd?
ACRO Biomedical Co Ltd pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de ACRO Biomedical Co Ltd?
La capitalización bursátil actual de ACRO Biomedical Co Ltd es $0
